ArticleTranslational lung cancer research2025
Efficacy and safety of immune checkpoint inhibitors in advanced non-small cell lung cancer with idiopathic interstitial pneumonia or interstitial lung abnormalities: NJLCG2301.
Fumihiko Okumura et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.